2024 Partners
Expertise Partner:
Uniphar
Uniphar is a trusted global partner to pharma, working to improve global patient access to medicines. Over the last 5 years, we have built unparalleled experience supporting our partners to accelerate patient access to cell and gene therapies around the globe.
Uniphar’s CGT experts harness the capabilities, infrastructure and experience of a diversified pharmaceutical service provider with more than 55 years’ building success stories with 200+ multinational clients.
Our understanding of the complex CGT requirements, market dynamics and barriers to access have allowed us to develop a fit-for-purpose CGT access platform which has delivered tailored solutions allowing more than 500 patients to access CGT treatments around the world.
Uniphar Pharma comprises Uniphar | Access, Uniphar | Medical, and Uniphar | Commercial – together our combined capabilities make us your trusted partner to unlock access to innovative therapies in countries where you might think it unachievable.
Innovation Partner:
CCX
CCX is a software company dedicated to building purpose-built tools to support pharma and payer market access teams. Our team has developed a suite of digital tools that supports a range of activities including access agreement planning, negotiation, and administration, helping teams operationalize their strategies, align internally and with external stakeholders, gain additional insights, and increase capacity for innovative contracting.
Innovation Partner:
Red Nucleus
The Market Access and Commercialization Services team within Red Nucleus is a global team of strategy experts with a shared passion for shaping value, navigating market access and optimizing price for pharma and biotech innovators.
Event Partner:
Magnolia Market Access
Magnolia Market Access provides tailored strategies and insights to pharmaceutical companies, device manufacturers, and trade associations meeting their market access, HEOR, and healthcare policy needs. Our experts provide 360-degree perspectives and analysis of our in-house and client specific clinical and real-world data to shape policy, communicate value, secure reimbursement, and drive patient access. Magnolia Market Access works with you to maximize access from the earliest stages of development through patent expiration and beyond.